BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15652502)

  • 21. Down-regulation of melanogenesis by phospholipase D2 through ubiquitin proteasome-mediated degradation of tyrosinase.
    Kageyama A; Oka M; Okada T; Nakamura S; Ueyama T; Saito N; Hearing VJ; Ichihashi M; Nishigori C
    J Biol Chem; 2004 Jun; 279(26):27774-80. PubMed ID: 15067002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The TSP motif in AP180 inhibits phospholipase D1 activity resulting in increased efficacy of anticancer drug via its direct binding to carboxyl terminal of phospholipase D1.
    Cho JH; Oh DY; Kim HJ; Park SY; Choi HJ; Kwon SJ; Lee KS; Han JS
    Cancer Lett; 2011 Mar; 302(2):144-54. PubMed ID: 21296491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of protein kinase calpha in the lysophosphatidic acid-induced bovine sperm acrosome reaction and phospholipase D1 regulation.
    Garbi M; Rubinstein S; Lax Y; Breitbart H
    Biol Reprod; 2000 Nov; 63(5):1271-7. PubMed ID: 11058529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PLD regulates myoblast differentiation through the mTOR-IGF2 pathway.
    Yoon MS; Chen J
    J Cell Sci; 2008 Feb; 121(Pt 3):282-9. PubMed ID: 18198186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phospholipase D is a target for inhibition of astroglial proliferation by ethanol.
    Burkhardt U; Wojcik B; Zimmermann M; Klein J
    Neuropharmacology; 2014 Apr; 79():1-9. PubMed ID: 24262632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Localization of phospholipase D1 to caveolin-enriched membrane via palmitoylation: implications for epidermal growth factor signaling.
    Han JM; Kim Y; Lee JS; Lee CS; Lee BD; Ohba M; Kuroki T; Suh PG; Ryu SH
    Mol Biol Cell; 2002 Nov; 13(11):3976-88. PubMed ID: 12429840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phorbol myristate acetate-dependent association of protein kinase C alpha with phospholipase D1 in intact cells.
    Lee TG; Park JB; Lee SD; Hong S; Kim JH; Kim Y; Yi KS; Bae S; Hannun YA; Obeid LM; Suh PG; Ryu SH
    Biochim Biophys Acta; 1997 Aug; 1347(2-3):199-204. PubMed ID: 9295164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Se-methylselenocysteine enhances PMA-mediated CD11c expression via phospholipase D1 activation in U937 cells.
    Lee TJ; Kim YH; Min do S; Park JW; Kwon TK
    Immunobiology; 2006; 211(5):369-76. PubMed ID: 16716806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phospholipase D1 activation through Src and Ras is involved in basic fibroblast growth factor-induced neurite outgrowth of H19-7 cells.
    Oh DY; Park SY; Cho JH; Lee KS; Min do S; Han JS
    J Cell Biochem; 2007 May; 101(1):221-34. PubMed ID: 17146759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural analysis of human phospholipase D1.
    Sung TC; Zhang Y; Morris AJ; Frohman MA
    J Biol Chem; 1999 Feb; 274(6):3659-66. PubMed ID: 9920915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delayed apoptosis and modulation of phospholipase D activity by plasmid containing mammalian cDNA in human neutrophils.
    Lee SY; Kim JW; Jin JO; Song MG; Park JI; Min do S; Kwak JY
    Biochem Biophys Res Commun; 2006 Sep; 347(4):1039-47. PubMed ID: 16870152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crosstalk between ARF6 and protein kinase Calpha in Fc(gamma)RI-mediated activation of phospholipase D1.
    Melendez AJ; Harnett MM; Allen JM
    Curr Biol; 2001 Jun; 11(11):869-74. PubMed ID: 11516649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potent direct inhibition of mammalian phospholipase D isoenzymes by calphostin-c.
    Sciorra VA; Hammond SM; Morris AJ
    Biochemistry; 2001 Feb; 40(8):2640-6. PubMed ID: 11327888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of phospholipase D isoenzymes by transforming Ras and atypical protein kinase C-iota.
    Mwanjewe J; Spitaler M; Ebner M; Windegger M; Geiger M; Kampfer S; Hofmann J; Uberall F; Grunicke HH
    Biochem J; 2001 Oct; 359(Pt 1):211-7. PubMed ID: 11563985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phospholipase D in platelets and other cells.
    Vorland M; Thorsen VA; Holmsen H
    Platelets; 2008 Dec; 19(8):582-94. PubMed ID: 19012176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinoic acid as a modulator of the activity of protein kinase Calpha.
    López-Andreo MJ; Torrecillas A; Conesa-Zamora P; Corbalán-García S; Gómez-Fernández JC
    Biochemistry; 2005 Aug; 44(34):11353-60. PubMed ID: 16114872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phospholipase D1: a key factor for the exocytotic machinery in neuroendocrine cells.
    Vitale N; Caumont AS; Chasserot-Golaz S; Du G; Wu S; Sciorra VA; Morris AJ; Frohman MA; Bader MF
    EMBO J; 2001 May; 20(10):2424-34. PubMed ID: 11350931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role for phospholipase D in receptor-mediated endocytosis.
    Shen Y; Xu L; Foster DA
    Mol Cell Biol; 2001 Jan; 21(2):595-602. PubMed ID: 11134345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetic analysis of a mammalian phospholipase D: allosteric modulation by monomeric GTPases, protein kinase C, and polyphosphoinositides.
    Henage LG; Exton JH; Brown HA
    J Biol Chem; 2006 Feb; 281(6):3408-17. PubMed ID: 16339153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Coffin-Lowry syndrome-associated protein RSK2 controls neuroendocrine secretion through the regulation of phospholipase D1 at the exocytotic sites.
    Zeniou-Meyer M; Béglé A; Bader MF; Vitale N
    Ann N Y Acad Sci; 2009 Jan; 1152():201-8. PubMed ID: 19161391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.